Novartis Withdraws Patent-Infringement Suit Against Krka
Warsaw, 1 April - Swiss drug maker Novartis has withdrawn its patent-infringement lawsuit against the Poland-based subsidiary of Slovenian drug maker Krka. The suit was filed with the Warsaw District Court in an attempt to prevent Krka Polska from selling valsacor pills and film-coated valsartan-based tablets under a different name in Poland.
The rest of this news item is available to subscribers.
The news item consists of 482 characters (without spaces) or 86 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.